Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.

NASDAQ Global SelectEquity ETF
$26.92
+$0.179 · +0.67%
At close: Oct 7, 4:00 PM ET
$26.79
−$0.13 · -0.48%
Pre-market · As of Oct 8, 5:53 AM ET
Regular session · ET · Market data may be delayed.
This exchange-traded fund, officially named the Defiance Daily Target 2X Short HIMS ETF (referred to as "the Fund"), is designed to deliver daily investment performance. Before accounting for fees and expenses, it seeks to provide results that are two times the inverse (-200%) of the day-to-day percentage shifts in the share price of Hims & Hers Health, Inc. (listed on the NYSE as HIMS). Given its strategy of seeking daily inverse leveraged returns, this Fund stands apart from most conventional exchange-traded funds, and there is no assurance that it will consistently meet its stated objective. Investors should be aware that holding this Fund for more than a single trading day means it is unlikely to achieve a cumulative return equal to -200% of HIMS's performance over that extended period.
Fund facts updated Oct 8, 2026.
Day range
Current $26.92
52-week range
Current $26.92
1 month
+5.61%
3 months
-48.48%
Year to date
-66.79%
1 year
-91.72%
Since inception
-88.70%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 11 of 11 reported holdings
Holdings data updated Oct 8, 2026.
Portfolio weights show the assets held by the fund; they do not represent its leveraged or inverse market exposure.
Dec 30, 2025
Dec 30, 2025
Dec 31, 2025
$1.974
Irregular
Amounts are shown per share in the ETF trading currency and adjusted for splits when the provider supplies an adjusted value; otherwise the reported amount is used.
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.